A detailed history of California State Teachers Retirement System transactions in 89bio, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 68,351 shares of ETNB stock, worth $602,855. This represents 0.0% of its overall portfolio holdings.

Number of Shares
68,351
Previous 70,573 3.15%
Holding current value
$602,855
Previous $565,000 10.62%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.36 - $9.66 $16,353 - $21,464
-2,222 Reduced 3.15%
68,351 $505,000
Q2 2024

Aug 14, 2024

SELL
$7.31 - $10.9 $32,375 - $48,276
-4,429 Reduced 5.91%
70,573 $565,000
Q1 2024

May 15, 2024

SELL
$8.13 - $13.77 $1,195 - $2,024
-147 Reduced 0.2%
75,002 $873,000
Q4 2023

Feb 13, 2024

BUY
$6.66 - $16.03 $109,024 - $262,411
16,370 Added 27.85%
75,149 $839,000
Q3 2023

Nov 14, 2023

SELL
$15.06 - $19.41 $100,405 - $129,406
-6,667 Reduced 10.19%
58,779 $907,000
Q2 2023

Aug 21, 2023

BUY
$14.15 - $22.03 $926,060 - $1.44 Million
65,446 New
65,446 $1.24 Million
Q2 2022

Aug 15, 2022

SELL
$2.09 - $4.02 $9,043 - $17,394
-4,327 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$3.45 - $14.99 $3,184 - $13,835
-923 Reduced 17.58%
4,327 $16,000
Q3 2021

Nov 15, 2021

SELL
$14.91 - $21.31 $122,053 - $174,443
-8,186 Reduced 60.93%
5,250 $103,000
Q2 2021

Aug 16, 2021

BUY
$17.42 - $28.0 $14,702 - $23,632
844 Added 6.7%
13,436 $251,000
Q4 2020

Feb 16, 2021

BUY
$23.16 - $28.08 $63,388 - $76,854
2,737 Added 27.77%
12,592 $307,000
Q3 2020

Nov 17, 2020

BUY
$24.34 - $38.82 $129,391 - $206,367
5,316 Added 117.12%
9,855 $253,000
Q1 2020

May 13, 2020

BUY
$16.4 - $41.77 $852 - $2,172
52 Added 1.16%
4,539 $115,000
Q4 2019

Feb 14, 2020

BUY
$19.75 - $33.44 $88,618 - $150,045
4,487 New
4,487 $118,000

Others Institutions Holding ETNB

About 89bio, Inc.


  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $410M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.